IP Library › Granted Patent US 7,582,459
Granted Patent B2
US 7,582,459 · App. 10/571,600 · Granted Sep 1, 2009

Process for producing a capsular polysaccharide for use in conjugate vaccines

Assignee: De Staat der Nederlanden, vert. door de minister van VWS
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,459
App. No.
10/571,600
Granted
Sep 1, 2009
Kind
B2
Abstract

A method for producing a polysaccharide and a conjugate vaccine including the polysaccharide produced according to the method. A characteristic step in the method is that the pH of the culture medium is kept at a constant value with base or acid until adjustment with respectively base or acid is not possible anymore. Using the method, capsular polysaccharide may be obtained in a high yield in a relatively short time. The method is straightforward, reproducible and cost-effective.

Claims (14)

1. A method for recovering a polysaccharide from a fermentation broth, comprising:

employing a cationic detergent to precipitate the polysaccharide or part of the contaminants from the supernatant to obtain a first polysaccharide fraction;

employing alcohol to precipitate the polysaccharide from the first polysaccharide fraction to obtain a second polysaccharide fraction;

subjecting the second polysaccharide fraction to an alcohol precipitation in the presence of an anionic detergent, whereby the alcohol is present in a concentration which is below a concentration at which the polysaccharide precipitates;

precipitating the polysaccharide from the soluble fraction employing alcohol to obtain a polysaccharide precipitate; and

dissolving the polysaccharide precipitate and subjecting it to concentration and diafiltration.

2. The method according to claim 1 , wherein the anionic detergent comprises sodium deoxycholate.

3. The method according to claim 1 , wherein the anionic detergent has a final concentration of about 0.1-1% w/v.

4. The method according to claim 1 , wherein the alcohol comprises ethanol.

5. The method according to claim 1 , wherein the alcohol during the step of employing alcohol to precipitate the polysaccharide from the first polysaccharide fraction to obtain a second polysaccharide fraction has a final concentration of about 60-74% v/v.

6. The method according to claim 1 , wherein the alcohol during the step subjecting the second polysaccharide fraction to an alcohol precipitation in the presence of an anionic detergent has a final concentration of about 10-50% v/v.

7. The method according to claim 1 , wherein the alcohol employed during the step of precipitation of the polysaccharide from the soluble fraction has a final concentration of about 60-85% v/v.

8. The method according to claim 1 , wherein the cationic surfactant comprises hexadecyltrimethyl ammonium bromide.

9. The method according to claim 1 , wherein the polysaccharide is obtained from Haemophilus influenza type b.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2009
From: NEDERLANDS VACCININSTITUUT
To: DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS
Reel/Frame 022565/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2006
From: HAMIDI, AHD; BEURRET, MICHEL FRANCOIS
To: NEDERLANDS VACCININSTITUUT
Reel/Frame 018476/0379 →
Priority Claims (1)
EP 03077881 · Sep 11, 2003 · regional
Continuity (1)
Related Publication 20070065460A1 · Mar 22, 2007